ARCHIVES

NIH institute directors, in response to question from Sen. Arlen Specter, say Bush Administration’s stem cell research policy is harmful to NIH leadership in science.

This article is from The Cancer Letter archive.

Vol. 31 No. 14 | April 8, 2005

Download PDF Visit The Full Archive

Related Articles

“Spoiled, Petulant Brat”: BioMarin CEO Fires Off Feisty Emails In Battle Over Access to PARP Inhibitor

November 8, 2013

ASCO Endorses Guideline for Molecular Testing

October 17, 2014

Senators Call Mammography Debate Confusing, Say Screening “Saves Lives”.

March 8, 2002

New NCI Directory

May 19, 1989

Conversations With The Cancer Letter: Youle: ACS Stance on Tobacco Sales Is Clear

April 18, 2014

In Congress: Human Genome Project Ahead Of Schedule, Collins Assert

March 27, 1998